Form 4 for XTNT Xtant Medical Holdings, Inc.
Accepted 2024-08-19 00:00:00 ET · period of report 2024-08-15 · accession 0001235802-24-000064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-19 | 2024-08-15 | XTNT | Browne Sean E | Pres, CEO, Dir | F - Tax | $0.6 | -10.6K | 2.30M | -0.5% | -$6,364 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-15 | F | D | 10,606 | $0.6 | 2,296,384 | D | — | — | (F1) These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards. (F2) Includes an aggregate of 862,294 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 433,024 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates. |